The CHESS trial: Protocol for the process evaluation of a randomised trial of an education and self-management intervention for people with chronic headache by Nichols, VP et al.
STUDY PROTOCOL Open Access
The CHESS trial: protocol for the process
evaluation of a randomised trial of an
education and self-management
intervention for people with chronic
headache
Vivien P. Nichols1, David R. Ellard1* , Frances E. Griffiths2, Martin Underwood1, Stephanie J. C. Taylor3,
Shilpa Patel1 and and on behalf of the CHESS team
Abstract
Background: Process evaluation is increasingly common alongside complex randomised controlled trials (RCTs).
This evaluation helps in understanding the mechanisms of impact and how the study processes were executed,
and it includes any contextual factors which may have implications for the trial results and any future
implementation. This process evaluation is for the Chronic Headache Education and Self-management Study
(CHESS) RCT, which is evaluating an education and self-management group behavioural intervention for people
with chronic headache. Chronic headache is defined as headaches which are present for 15 or more days per
month. The most common types are chronic migraine and chronic tension type and medication overuse
headaches.
Methods: We will use a mixed methods approach. Quantitative data will be taken from routine trial data which will
help us to assess the reach of the study; i.e. did we reach those whom we expected and from where? Intervention
attendance (dose received) and attrition and qualitative data will augment our understanding about reasons why
people may not wish to take part in or failed to attend sessions. Interviews with intervention facilitators and trial
participants will gain different perspectives on taking part in the trial.
Fidelity will be assessed through listening to audio recordings for adherence to course content and competence of
the facilitation of a sample of sessions.
Discussion: Our process evaluation will allow us to gain insight into how the trial was delivered, the obstacles and
enablers encountered and the possible reasons why the interventions may or may not be effective.
Trial registration: ISRCTN79708100. Registered on 16 December 2015.
Keywords: Process evaluation, Chronic headache, Self-management, Chronic migraine, Chronic tension type
headache and medication overuse headache
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Background
Health research interventions are becoming increasingly
complex, encompassing many interconnecting and inter-
acting components [1]. The primary outcome is the core
focus of randomised controlled trials (RCTs) of complex
interventions in health care. Nevertheless, consideration
of the study processes, including design and execution,
can be equally important. Evaluation of the principal
processes of a complex study assists in elucidating why a
particular intervention is, or is not, successful in achiev-
ing its outcome. It may also help to explain how an
intervention could be optimised or why it may have
failed [1–3]. There is now a growing body of published
process evaluations that help to put trial results into
context [4–8]. Having a clear understanding of the pro-
cesses of a study is also very helpful for study replication
and for informing future research.
Key components of process evaluation, including
reach, recruitment, treatment fidelity, dose delivered and
dose received, help to define the extent to which an
intervention is implemented [3]. This structured process
helps to identify problems and factors that may have
caused a deviation in expected outcomes. For example,
it may highlight contextual factors which could have im-
pacted the trial implementation, which might not other-
wise have become apparent.
The Chronic Headache Education and Self-management
Study (CHESS) has a full study protocol compliant with
Standard Protocol Items: Recommendations for Interven-
tional Trials (SPIRIT) guidelines, which is available includ-
ing checklist and figure. Within this protocol is an outline
of the process evaluation planned for CHESS (Patel S, et
al., Usual Care and a Self-Management Support
Programme vs Usual Care and a Relaxation Programme
for People Living with Chronic Headache Disorders: A
Randomised Controlled Trial Protocol (CHESS), submit-
ted). To ensure scientific rigour (in research conduct and
reporting) we present here a more detailed protocol for
the process evaluation being undertaken within CHESS.
This protocol, as a component of the main CHESS proto-
col, does not fit within the SPIRIT framework, as it is not
a full interventional trial protocol.
In the CHESS study chronic headache is defined as
one which is present for 15 or more days per month for
at least 3 months [9]. It affects between 3 and 4% of the
population [10]. Medication overuse headache (medica-
tion overuse being both a consequence of, and a cause
of, chronic headache) affects between a quarter and a
half of those with chronic headaches. Despite the scale
of the disability associated with chronic headache world-
wide [11], there have been very few studies exploring
how to support people to manage their headaches better.
The CHESS trial is testing the impact of a supportive
group self-management programme on the headache-
related quality of life in people living with chronic
headaches.
Before entering the CHESS trial all participants take
part in a headache classification interview via telephone
(Potter R, et al., Development and Validation of a Tele-
phone Classification Interview for Common Chronic
Headache Disorders, submitted). This ensures all partici-
pants have chronic migraine (CM) or chronic tension type
headache (CTTH), in the presence or absence of medica-
tion overuse headache (MOH). All study participants and
their general practitioners (GPs) are given current
evidence-based advice about their type of headache and
medication options. The CHESS intervention arm consists
of a 2-day educational and self-management group inter-
vention held in a local community setting, followed by an
individual face-to-face session. In this session a nurse dis-
cusses the participant’s classification, medication options
and the personal goals they have or plan to set. They will
then mutually agree on the amount of telephone support
they would like, over the following 8 weeks. The control
arm patients receive usual care plus a relaxation CD. They
and their GPs also receive feedback on the classification
interview. More detailed information on the CHESS study
can be found in the previously mentioned study protocol
of S. Patel et al.
The trial and the process evaluation described are both
funded by a National Institute for Health Research (NIHR)
programme grant, project number RP-PG-1212-20018
(https://www.journalslibrary.nihr.ac.uk/programmes/pgfar/
RP-PG-1212-20018/#/). Ethics approval has been granted
for the trial and its process evaluation by the North
West-Greater Manchester East Research Ethics Committee.
The trial registration number is ISRCTN 79708100.
Formative process evaluation pre main trial
A formative process evaluation undertaken during the
feasibility study preceding the main trial was used to re-
fine intervention delivery and recruitment procedures in
the main trial. Data collection included recruitment rates
and observations and interviews with study participants
and facilitators. Participants enjoyed meeting other
people with chronic headaches in a group setting, but at
interview suggested reducing the length of the group
intervention due to the pressures of work and family
commitments. This was also a major reason given for
being unable to take part in the feasibility study and/or
attending the group intervention. Following participants’
suggestions, the course duration and content were
reduced to 2 days separated by a week instead of having
2 consecutive days followed by a shorter day a week later
[12]. The group session content was well received, and
even when elements were not personally useful, inter-
viewees felt that all the content was potentially useful to
others. Some talked of gaining new knowledge, and
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others had tried some of the techniques suggested. The
trial paperwork (e.g. questionnaires and diaries) was not
considered to be a burden.
The intervention group facilitators felt they needed
further training and guidance on medication for head-
aches. This training was expanded for the main study.
Lay facilitators with experience of frequent headaches
helped to deliver the feasibility group intervention. How-
ever, they were always uncertain as to whether they
would be able to attend on a scheduled day due to the
unpredictability of their headaches. The team reluctantly
made a pragmatic decision to use nurses with other al-
lied health professionals only to deliver the intervention
in the main study. In the following subsections we
present the aims and objectives of the main CHESS
process evaluation.
Aims
Here we present the protocol for the process evaluation
of the CHESS RCT.
The aims of the process evaluation are:
1. To assist in the interpretation of the results of the
main effectiveness trial
2. To develop a set of transferable principles regarding
the intervention to inform its implementation on a
wider scale, if the intervention proves effective.
Objectives
Our specific objectives are:
 To monitor implementation processes, i.e.
recruitment, reach, dose delivered, dose received,
delivery of the intervention and acceptability/use of
the intervention in practice and fidelity
 To explore participants’ experiences of living with
chronic headaches whilst taking part in the trial and
to explore any ongoing use and experience of the
intervention through in-depth interviews
 To explore with members of the recruitment team
and the intervention delivery teams their
experiences and possible facilitators and barriers to
wider implementation.
Methods
Rationale for our approach
The process evaluation has been developed within a
framework based on the Medical Research Council
(MRC) guidance and incorporates components of the
process evaluation model proposed by Steckler and Lin-
nan, which includes context, reach, dose delivered, dose
received, fidelity and recruitment [1, 3]. We are adopting
a mixed methods approach for the process evaluation
[13–15]. The principal data collection method will be
quantitative, whilst qualitative data will complement the
quantitative data, providing a depth and breadth of un-
derstanding. We will add to this an exploration of the
experience of delivering and receiving the intervention
to inform any future rollout of the intervention and the
early impact of the intervention. In Fig. 1 we present the
key functions of the CHESS process evaluation. Whilst it
appears to be a linear progression, feedback loops
between components within the framework may occur
at all stages, as illustrated by the black arrows. This re-
flects the process where intervention descriptions and
causal assumptions may need revisiting. Emerging in-
sights into mechanisms triggered by the intervention
may have an impact on implementation.
The process evaluation within the CHESS study has a
dedicated team who are part of the overall team but who
are not involved in delivering the intervention or meas-
uring its effectiveness. The team will meet regularly and
will be responsible for the process evaluation, data
collection, analysis and final report.
The data from this summative process evaluation will
be analysed separately from the main trial results and
presented before the main outcomes are reported. It will
contribute to a review of the a priori analysis plan before
trial analysis commences [13].
Quantitative data
To determine the study recruitment reach and context,
we will collect routine trial recruitment data to assess if
we reached our populations of interest across different
geographic locations. We will also collect data, where
possible, on why people do not want to participate in
the study from the expression of interest forms (which
will include a number of options participants can choose
if they do not want to participate) or why people who
initially want to take part may subsequently be unable to
participate (e.g. from notes to file following contact with
a participant who drops out).
Qualitative data
A focus group or individual interviews will be carried




To determine the dose delivered and the dose received,
we will collect data on the numbers and locations of the
groups run. We will use attendance sheets to collect
which group sessions and individual sessions were
attended and how many of the support telephone calls
were received. Table 1 lists the quantitative data sources.
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Qualitative data
We will use semi-structured interviews with participants
and focus groups or interviews with intervention staff to
ascertain their experiences of being in the study. The
qualitative data will be used to enhance the quantitative
data and provide insight into how the intervention may
or may not have been accessed, utilised and/or inter-
acted with. Our decision to offer staff the option of
interview or focus group was a pragmatic and practical
one. Our preference is the group setting, as it will give
the opportunity for discussion from different perspec-
tives as participants reflect on their experiences.
Fig. 1 The CHESS process evaluation. The process evaluation components are highlighted in the shaded boxes. Informed by the intervention
description which informs interpretation of outcome (adapted from Moore et al., [1])
Table 1 Quantitative data sources
Item Source Description
Dose delivered Trial intervention data Numbers of groups delivered/not delivered
and why, location of groups
Dose received Trial intervention attendance sheets for groups, one-to-one
nurse consultations and telephone calls
Attendance and attrition data
Nichols et al. Trials          (2019) 20:323 Page 4 of 8
However, gathering groups of people together has its
problems, so those who cannot attend will be offered an
interview so that they too can have a voice.
Participant interviews
All consenting participants in the main trial will indicate
if they would be willing to be approached for an inter-
view. The process evaluation team will select and invite
a purposive sample of these participants based on their
headache type.
To understand the participant’s journey, we will carry
out semi-structured interviews with a purposive sample
of approximately 30 participants from both the usual
care and intervention arms at three time points. Trial
participants will be sent a separate patient information
leaflet explaining the purpose of the interviews. They
will then be contacted a week later, and any questions
will be answered. Consent will be taken at the first inter-
view but reconfirmed verbally before each subsequent
interview. Interviews will be performed face to face at
the first two interviews and by telephone at the last. The
first interview will be held after consent and classifica-
tion but prior to randomisation, the second and third
after participants have returned their 4 and 12 months
questionnaires respectively. We will use framework ana-
lysis to interpret the data through a phenomenological
lens seeking to understand the participants’ experience
as they move through the different stages of the research
[15, 16]. First we will study their present lived experi-
ence of headaches and their expectations of being on the
study, then their experiences of engaging (or not) with
the study and finally their view of any long-term impact.
Issues or comments raised at the first interview will be
addressed at subsequent interviews, and data analysis
will take place iteratively throughout data collection.
All intervention staff will be invited to be interviewed
individually or in focus groups at the end of the inter-
vention delivery. We will also ask participating GP prac-
tices to complete a feedback form. Table 2 outlines the
qualitative data, its purpose and its time points within
the study.
Qualitative work will add to the richness of the data
by providing a deeper understanding of what the partici-
pants thought about attending the course, including
whether they learned anything new or changed their
management of their headaches specifically by changing
their medication and/or behaviour.
Fidelity
Fidelity will be assessed from audio recordings of a
selection of group sessions. Key sessions from the whole
course were identified by the intervention development
team in collaboration with the process evaluation team.
These sessions were considered to be the most likely to
promote behaviour change and deliver new knowledge
(see Table 3). The other sessions concerned practical
techniques and lifestyle advice. An overall impression of
the course as a whole will be explored through partici-
pant and staff interviews and feedback.
Using a random number generator in Microsoft Excel
(2007), we created two randomisation tables (allowing
for up to 40 groups in the Midland area and 20 groups
in the London area to be delivered). To ensure all
groups were represented and to minimise bias, groups
Table 2 Qualitative data purposes and time points
Stakeholder Purpose Time point
Participant’s 1st To explore: Post consent and pre
interview • Expectations of the CHESS intervention randomisation
• Experiences of living with chronic headaches
• Trial experiences
Participant’s To explore: Post 4 months questionnaire
2nd interview • Reflection on trial experiences
• Current headache experiences
• Use of the trial materials
• Early impact
Participant’s To explore: Post 12 months questionnaire
3rd interview • Further reflection on trial experiences
• Current headache experiences
• Use of the trial materials
• Early impact
Intervention staff To understand their experiences of delivering the intervention End of all trial intervention delivery
GP feedback To understand their trial experiences End of practice patient’s involvement
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were numbered consecutively, and three sessions and a
back-up session were randomly assigned to each group.
One member of the process evaluation team will listen
to the audio recorded sessions and will rate them on ad-
herence (whether they delivered the content as per the
manual) and competence (how well the course leaders
facilitated the sessions). The marking criteria will be evi-
dent, partially evident and not evident. Scores of 2/1/0
respectively will be given. A second researcher will rate
10% of these sessions to ensure inter-rater reliability and
credibility of the scoring process.An example of an as-
sessment table is given in Additional file 1.
Initially we were going to observe 10% of the interven-
tion groups and collect data specifically about the group
dynamics and the sessions not covered in the fidelity
assessments to gain an overall impression of the inter-
vention. We decided to obtain this information from the
staff and group participants at interview to gain more
information across a potentially larger number of group
interventions.
One-to-one nurse consultations follow a set format
with a structured form. On listening to two sessions at
three time points (early, middle and late in the trial), we
decided that the forms were comprehensive in collecting
information about whether the key components of head-
ache classification, medication and goal setting were dis-
cussed. We will look at a random sample of 10% of
these forms to assess adherence and note the uptake of
follow-up telephone calls numerically as well qualita-
tively in any comments given at interview.
Early impact
Questions within the second and third interviews with
participants will explore to what extent the participants
are making use of the intervention materials now that
they are approaching the end of the study. The inter-
viewers will ask the participants for any real examples of
what, when and how they are using the materials now
and their experiences of whether these materials may or
may not have been integrated into their lives (e.g.
whether there is an impact on their headaches and or
quality of life).
Pre RCT results
It is the aim of the process evaluation team to provide a
process evaluation report before the main trial effective-
ness results are revealed. This will be presented to the
Chief Investigator and the Trial Management Group for
consideration. Dependent on the outcomes, there may
be recommendations for possible subgroup analyses.
Data analysis
Quantitative data will be entered onto the study data-
base, and appropriate descriptive statistics, charts, tables
or figures will be produced.
Qualitative data including interviews and feedback
forms will be analysed using the framework method pro-
posed by Ritchie and Spencer [16]. We will use frame-
work analysis and comparative analysis to interpret the
data as participants move through the different stages of
the research. The interviews will be audio recorded on
an encrypted digital recorder and transcribed verbatim;
recordings will be anonymised before analysis. All data
will be kept in a digitally safe environment.
Discussion
Over the last few years the importance of a well-con-
ducted process evaluation of complex trials has in-
creased. Trials now go much further than determining
effectiveness of an intervention. There is now a need to
know and understand how or why an intervention was
successful or not. Process evaluations have to be a fun-
damental consideration during trial development, and to
ensure high standards of research conduct and report-
ing, clear protocols should be produced and made avail-
able in the public domain during the trial development.
Here we have produced a more detailed process evalu-
ation protocol taken from the CHESS main study proto-
col to provide a deeper understanding of exactly what
we are planning to do and how we will report it. This
Table 3 Key components of the group intervention
Day Session number Session name
1 3 Headache information and mechanisms
1 4 Acceptance of chronic headaches
1 5 Impact of thoughts, mood and emotions on headaches
1 6 Headache cycle and breaking the cycle
1 7 Unhelpful thinking patterns and finding alternatives
2 10 Identifying barriers to change and exploring problem
solving and goal setting
2 17 Communicating better with health care professionals
2 18 Managing setbacks: what to do when things don’t go
according to plan
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we hope will help us to interpret the trial results and
place them in context.
In summary, this process evaluation will explore the
trial processes of CHESS and show whether the trial was
delivered as intended and whether there were factors
which affected its implementation.
Trial status
The main CHESS trial started recruitment in mid-2017,
and recruitment concluded at the end of March 2019.
Additional files
Additional file 1: Process evaluation protocol for the CHESS trial:
supplementary material. (DOCX 19 kb)
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